Varant Arzoumanian, MD
Hematology & Oncology · Fort Smith, ARNPI 1790904027
Payments from drug & device makers
Across 457 payments — averaging $16.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$1K
- AstraZeneca$804
- Novartis$598
- Gilead$588
- Merck$573
- Daiichi Sankyo Inc.$385
- plus $4K from 33 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 77 | $1,032 |
| AstraZeneca | 44 | $804 |
| Novartis | 32 | $598 |
| Gilead(2 entities) | 37 | $588 |
| Merck | 37 | $573 |
| Daiichi Sankyo Inc. | 19 | $385 |
| Rigel Pharmaceuticals, Inc. | 24 | $382 |
| Johnson & Johnson(2 entities) | 22 | $325 |
| AbbVie | 15 | $304 |
| GSK | 19 | $292 |
| Myovant Sciences Inc. | 14 | $216 |
| Astellas Pharma US Inc | 13 | $213 |
| Eisai Inc. | 11 | $198 |
| Amgen | 12 | $181 |
| Bristol Myers Squibb | 7 | $129 |
| Lilly USA, LLC | 8 | $122 |
| Pharmacyclics LLC, An Abbvie Company | 3 | $117 |
| EMD Serono, Inc. | 7 | $117 |
| Array Biopharma Inc | 8 | $112 |
| Puma Biotechnology, Inc. | 6 | $103 |
| Genentech USA, Inc. | 5 | $84 |
| Sumitomo Pharma America, Inc. | 3 | $62 |
| Seagen Inc. | 4 | $58 |
| Jazz Pharmaceuticals Inc. | 3 | $54 |
| Ipsen Biopharmaceuticals, Inc | 3 | $50 |
| Boehringer Ingelheim | 3 | $46 |
| Foundation Medicine, Inc. | 3 | $44 |
| Beigene USA, Inc. | 3 | $42 |
| Recordati_rare_diseases_inc. | 2 | $40 |
| Epizyme, Inc. | 2 | $34 |
| Sanofi | 2 | $28 |
| E.r. Squibb & Sons, L.L.C. | 2 | $26 |
| Syndax Pharmaceuticals, Inc. | 1 | $24 |
| Sobi, Inc | 1 | $22 |
| Servier Pharmaceuticals LLC | 1 | $20 |
| Menarini Silicon Biosystems, Inc. | 1 | $20 |
| Acceleron Pharma, Inc. | 1 | $16 |
| Tolmar Pharmaceuticals, Inc. | 1 | $16 |
| Pharmacosmos Therapeutics Inc. | 1 | $13 |
How this compares
$7,489 in reported general payments places this provider in the 50th percentile of 92 hematology & oncology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology & oncology in Fort Smith
- Isam Abdel-KarimFort Smith$658K
- Humdum DurraniFort Smith$324K
- Narender GorukantiFort Smith$20K
- Tony FlippinFort Smith$18K
- Daniel MackeyFort Smith$6K
- Aswanth ReddyFort Smith$5K
- John WellsFort Smith$5K
- Joseph BeckFayetteville$33.8M
- Eric SchaeferFayetteville$5.2M
- Ryan HallLittle Rock$4.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.